Eugia US Manufacturing LLC, a wholly-owned subsidiary of Aurobindo Pharma, has entered into an agreement with Empower Clinic Services New Jersey, LLC to divest its business assets in a transaction valued at more than $52 million.
Under an asset purchase agreement, the business assets are disposed of as a going concern, with related assets, liabilities and employees, as capabilities and operations are consolidated in other units of the company. Upon closing of the deal, it will enter into a contract manufacturing arrangement with the buyer, Aurobindo said in a statement on Monday. The pharmaceutical company's shares closed 4.53% lower at Rs 1,018.05 per piece on the Bahrain Stock Exchange.
Regarding this amount, Aurobindo said that $52 million will be received from the sale as well as $58 million in lease payments made to Eugia US Manufacturing LLC and/or its affiliates, over the 20-year lease term including extensions.
This is a featured article available exclusively to our subscribers. To read more than 250 featured articles every month
You've exhausted your free articles limit. Please support quality journalism.
You've exhausted your free articles limit. Please support quality journalism.
I had read {{data.cm.views}} Out of place {{data.cm.maxViews}} Free articles.
This is your final free article.
